Endo In Deal With Quoin Pharmaceuticals To Develop And Sell Quoin's QRX003 In Canada

Endo International plc (ENDP) Friday said its subsidiary, Endo Ventures Limited has entered into deal with Quoin Pharmaceuticals Inc. (QNRX) to develop and sell the latter's QRX003 in Canada.

QRX003, a topical lotion formulated with a proprietary delivery technology, is Quoin's lead product for Netherton syndrome, a rare congenital skin disorder.

If the product is approved, Paladin Labs Inc., an operating company of Endo, will do all commercial activities in Canada, Endo said in a statement.

In April this year, Quoin had received clarence from the FDA to initiate clinical studies for its Investigational New Drug application for QRX003.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Tesla CEO Elon Musk announced that the luxury electric vehicle maker has started the production of Tesla Semi electric trucks, and the first delivery will be to food and beverages giant Pepsico Inc. starting December 1. In a tweet, Musk said, "Excited to announce start of production of Tesla Semi Truck with deliveries to @Pepsi on Dec 1st!" Ford Motor is increasing the entry-level price of its electric F-150 Lightning pickup citing rising costs and supply chain issues amid increasing demand. This is the second price hike after a recent increase in August. The starting price of the 2023 model year pickup will be raised by $5,000 by October 24, reports said citing an email statement. Constellation Brands, Inc. (STZ) said it delivered another quarter of strong business performance. Beer Business achieved double-digit net sales growth for the quarter, while Wine and Spirits net sales rose 1%. The solid top-line performance of its Beer and Wine and Spirits Businesses in the first half...
Follow RTT